Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis

G. Almer, C. Guegan, Peter Teismann, A. Naini, G. Rosoklija, A. P. Hays, C. Chen, S. Przedborski

Research output: Contribution to journalArticle

229 Citations (Scopus)

Abstract

Mutations in the copper/zinc superoxide dismutase (mSOD1) gene are associated with a familial form of amyotrophic lateral sclerosis (ALS), and their expression in transgenic mice produces an ALS-like syndrome. Recent observations suggest a role for inflammatory-related events in the progression and propagation of the neurodegenerative process in ALS. Consistent with this view, the present study demonstrates that, during the course of the disease, the expression of cyclooxygenase type 2 (Cox-2), a key enzyme in the synthesis of prostanoids, which are potent mediators of inflammation, is dramatically increased. In both early symptomatic and end-stage transgenic mSOD1 mice, neurons and, to a lesser extent, glial cells in the anterior horn of the spinal cord exhibit robust Cox-a immunoreactivity. Cox-2 mRNA and protein levels and catalytic activity are also significantly increased in the spinal cord of the transgenic mSOD1 mice. The time course of the spinal cord Cox-2 upregulation parallels that of motor neuronal loss in transgenic mSOD1 mice. We also show that Cox-2 activity is dramatically increased in postmortem spinal cord samples from sporadic ALS patients. We speculate that Cox-2 upregulation, through its pivotal role in inflammation, is instrumental in the ALS neurodegenerative process and that Cox-2 inhibition may be a valuable therapeutic avenue for the treatment of ALS.

Original languageEnglish
Pages (from-to)176-185
Number of pages9
JournalAnnals of Neurology
Volume49
Issue number2
DOIs
Publication statusPublished - 1 Feb 2001

Keywords

  • transgenic mouse model
  • nitric-oxide synthase
  • motor-neuron degeneration
  • superoxide-dismutase
  • animal-model
  • familial ALS
  • inducible cyclooxygenase
  • phospholipase A(2)
  • oxidative damage
  • cerebral-cortex

Cite this

Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. / Almer, G.; Guegan, C.; Teismann, Peter; Naini, A.; Rosoklija, G.; Hays, A. P.; Chen, C.; Przedborski, S.

In: Annals of Neurology, Vol. 49, No. 2, 01.02.2001, p. 176-185.

Research output: Contribution to journalArticle

Almer, G, Guegan, C, Teismann, P, Naini, A, Rosoklija, G, Hays, AP, Chen, C & Przedborski, S 2001, 'Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis', Annals of Neurology, vol. 49, no. 2, pp. 176-185. https://doi.org/10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X
Almer, G. ; Guegan, C. ; Teismann, Peter ; Naini, A. ; Rosoklija, G. ; Hays, A. P. ; Chen, C. ; Przedborski, S. / Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. In: Annals of Neurology. 2001 ; Vol. 49, No. 2. pp. 176-185.
@article{a2efecad68534a429f08783fc67bfccc,
title = "Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis",
abstract = "Mutations in the copper/zinc superoxide dismutase (mSOD1) gene are associated with a familial form of amyotrophic lateral sclerosis (ALS), and their expression in transgenic mice produces an ALS-like syndrome. Recent observations suggest a role for inflammatory-related events in the progression and propagation of the neurodegenerative process in ALS. Consistent with this view, the present study demonstrates that, during the course of the disease, the expression of cyclooxygenase type 2 (Cox-2), a key enzyme in the synthesis of prostanoids, which are potent mediators of inflammation, is dramatically increased. In both early symptomatic and end-stage transgenic mSOD1 mice, neurons and, to a lesser extent, glial cells in the anterior horn of the spinal cord exhibit robust Cox-a immunoreactivity. Cox-2 mRNA and protein levels and catalytic activity are also significantly increased in the spinal cord of the transgenic mSOD1 mice. The time course of the spinal cord Cox-2 upregulation parallels that of motor neuronal loss in transgenic mSOD1 mice. We also show that Cox-2 activity is dramatically increased in postmortem spinal cord samples from sporadic ALS patients. We speculate that Cox-2 upregulation, through its pivotal role in inflammation, is instrumental in the ALS neurodegenerative process and that Cox-2 inhibition may be a valuable therapeutic avenue for the treatment of ALS.",
keywords = "transgenic mouse model, nitric-oxide synthase, motor-neuron degeneration, superoxide-dismutase, animal-model, familial ALS, inducible cyclooxygenase, phospholipase A(2), oxidative damage, cerebral-cortex",
author = "G. Almer and C. Guegan and Peter Teismann and A. Naini and G. Rosoklija and Hays, {A. P.} and C. Chen and S. Przedborski",
year = "2001",
month = "2",
day = "1",
doi = "10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X",
language = "English",
volume = "49",
pages = "176--185",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis

AU - Almer, G.

AU - Guegan, C.

AU - Teismann, Peter

AU - Naini, A.

AU - Rosoklija, G.

AU - Hays, A. P.

AU - Chen, C.

AU - Przedborski, S.

PY - 2001/2/1

Y1 - 2001/2/1

N2 - Mutations in the copper/zinc superoxide dismutase (mSOD1) gene are associated with a familial form of amyotrophic lateral sclerosis (ALS), and their expression in transgenic mice produces an ALS-like syndrome. Recent observations suggest a role for inflammatory-related events in the progression and propagation of the neurodegenerative process in ALS. Consistent with this view, the present study demonstrates that, during the course of the disease, the expression of cyclooxygenase type 2 (Cox-2), a key enzyme in the synthesis of prostanoids, which are potent mediators of inflammation, is dramatically increased. In both early symptomatic and end-stage transgenic mSOD1 mice, neurons and, to a lesser extent, glial cells in the anterior horn of the spinal cord exhibit robust Cox-a immunoreactivity. Cox-2 mRNA and protein levels and catalytic activity are also significantly increased in the spinal cord of the transgenic mSOD1 mice. The time course of the spinal cord Cox-2 upregulation parallels that of motor neuronal loss in transgenic mSOD1 mice. We also show that Cox-2 activity is dramatically increased in postmortem spinal cord samples from sporadic ALS patients. We speculate that Cox-2 upregulation, through its pivotal role in inflammation, is instrumental in the ALS neurodegenerative process and that Cox-2 inhibition may be a valuable therapeutic avenue for the treatment of ALS.

AB - Mutations in the copper/zinc superoxide dismutase (mSOD1) gene are associated with a familial form of amyotrophic lateral sclerosis (ALS), and their expression in transgenic mice produces an ALS-like syndrome. Recent observations suggest a role for inflammatory-related events in the progression and propagation of the neurodegenerative process in ALS. Consistent with this view, the present study demonstrates that, during the course of the disease, the expression of cyclooxygenase type 2 (Cox-2), a key enzyme in the synthesis of prostanoids, which are potent mediators of inflammation, is dramatically increased. In both early symptomatic and end-stage transgenic mSOD1 mice, neurons and, to a lesser extent, glial cells in the anterior horn of the spinal cord exhibit robust Cox-a immunoreactivity. Cox-2 mRNA and protein levels and catalytic activity are also significantly increased in the spinal cord of the transgenic mSOD1 mice. The time course of the spinal cord Cox-2 upregulation parallels that of motor neuronal loss in transgenic mSOD1 mice. We also show that Cox-2 activity is dramatically increased in postmortem spinal cord samples from sporadic ALS patients. We speculate that Cox-2 upregulation, through its pivotal role in inflammation, is instrumental in the ALS neurodegenerative process and that Cox-2 inhibition may be a valuable therapeutic avenue for the treatment of ALS.

KW - transgenic mouse model

KW - nitric-oxide synthase

KW - motor-neuron degeneration

KW - superoxide-dismutase

KW - animal-model

KW - familial ALS

KW - inducible cyclooxygenase

KW - phospholipase A(2)

KW - oxidative damage

KW - cerebral-cortex

U2 - 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X

DO - 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X

M3 - Article

VL - 49

SP - 176

EP - 185

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 2

ER -